Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62.7M
-
Number of holders
-
248
-
Total 13F shares, excl. options
-
50.4M
-
Shares change
-
-2.84M
-
Total reported value, excl. options
-
$2.86B
-
Value change
-
-$183M
-
Put/Call ratio
-
2.1
-
Number of buys
-
130
-
Number of sells
-
-116
-
Price
-
$56.81
Significant Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q2 2021
321 filings reported holding SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") as of Q2 2021.
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) has 248 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.4M shares
of 62.7M outstanding shares and own 80.51% of the company stock.
Largest 10 shareholders include FMR LLC (6.86M shares), WELLINGTON MANAGEMENT GROUP LLP (5.81M shares), VANGUARD GROUP INC (4.82M shares), BlackRock Inc. (2.85M shares), Bellevue Group AG (2.36M shares), JANUS HENDERSON GROUP PLC (1.66M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.57M shares), Artisan Partners Limited Partnership (1.52M shares), STATE STREET CORP (1.34M shares), and D. E. Shaw & Co., Inc. (1.32M shares).
This table shows the top 248 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.